Spleen tyrosine kinases: biology, therapeutic targets and drugs.

Article Details

Citation
Copy to clipboard

Riccaboni M, Bianchi I, Petrillo P

Spleen tyrosine kinases: biology, therapeutic targets and drugs.

Drug Discov Today. 2010 Jul;15(13-14):517-30. doi: 10.1016/j.drudis.2010.05.001. Epub 2010 May 27.

PubMed ID
20553955 [ View in PubMed
]
Abstract

Spleen tyrosine kinase (Syk) is an intriguing protein tyrosine kinase involved in signal transduction in a variety of cell types, and its aberrant regulation is associated with different allergic disorders and antibody-mediated autoimmune diseases such as rheumatoid arthritis, asthma and allergic rhinitis. Syk also plays an important part in the uncontrolled growth of tumor cells, particularly B cells. For these reasons, Syk is considered one of the most interesting biological targets of the last decade, as proved by the great number of papers and patents published, and the possibility of treating these pathologies by means of Syk kinase inhibitors has led to a great interest from the pharmaceutical and biotech industry.

DrugBank Data that Cites this Article

Drugs